QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

KNSA

QT77Kiniksa Pharmaceuticals, Ltd.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
55.11
+0.90+1.66%
OverviewShort InterestFilings
KNSAQT77Kiniksa Pharmaceuticals, Ltd.·NASDAQ
OverviewShort InterestFilings
55.11+1.66%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E56.78EPS (ttm)
0.91
Insider Own5.82%
Shs Outstand76.94M
Perf Week6.84%
Market Cap4.08BForward P/E28.78EPS next Y1.91Insider Trans1.21%Shs Float-Perf Month3.32%
Enterprise Value3.89BPEG0.02EPS next Q0.30Inst Own-Short Float-Perf Quarter20.78%
Income71.72MP/S5.40EPS this Y50.79%Inst Trans-Short Ratio-Perf Half Y33.21%
Sales754.05MP/B6.85EPS next Y39.55%ROA8.85%Short Interest-Perf YTD33.60%
Book/sh7.88P/C25.01EPS next 5Y34.06%ROE13.26%52W High59.87 -7.95%Perf Year97.17%
Cash/sh6.08P/FCF24.81EPS past 3/5Y-ROIC9.56%52W Low26.27 109.78%Perf 3Y-
Dividend Est.-EV/EBITDA36.17Sales past 3/5Y45.52% -Gross Margin54.63%Volatility1.94% 2.57%Perf 5Y-
Dividend TTM-EV/Sales5.16EPS Y/Y TTM250.00%Oper. Margin12.36%ATR (14)1.96Perf 10Y-
Dividend Ex-Date-Quick Ratio3.33Sales Y/Y TTM78.25%Profit Margin9.69%RSI (14)63.69Recom2.00
Dividend Gr. 3/5Y-Current Ratio3.79EPS Q/Q145.45%SMA208.47%Beta0.24Target Price64.00
Payout0.00%Debt/Eq0.01Sales Q/Q55.07%SMA507.82%Rel Volume1.14Prev Close54.21
Employees315LT Debt/Eq0.01EarningsJul 28SMA20025.32%Avg Volume683.48KPrice55.11
IPO DateMay 25, 2018Option/ShortYes / YesEPS/Sales Surpr.50.00% 3.88%Net Debt/EBITDA-1.68Volume776,737Change1.66%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-29-26ReiteratedWedbushOutperform$58 → $59
Apr-28-26ReiteratedJefferiesBuy$54 → $71
Apr-16-26ReiteratedWedbushOutperform$50 → $58
Feb-19-26InitiatedCanaccordBuy$62
Jan-13-26ReiteratedWedbushOutperform$44 → $50
Oct-29-25ReiteratedGoldman SachsBuy$55
Oct-13-25ReiteratedWedbushOutperform$44
Jul-29-25ReiteratedJefferiesBuy$40 → $54
Oct-29-24ReiteratedEvercore ISI$35
Sep-13-24ReiteratedJefferies$40
Latest News
Jun-10-26
Jun-10-2601:22AM
Kiniksa Pharmaceuticals International, plc (KNSA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue754678423
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A34230761
Gross Profit412370362
Selling, General and Administrative Excl. Other214196168
Research and Development10597112
Other Operating Expense00128
Operating Income9377-46
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-13-12-9
Net Income Before Taxes10689-36
Income Taxes33307
Consolidated Net Income7359-43
Net Income From Continuing Operations7359-43
Net Income7359-43
EPS (Recurring)0.980.80-0.60
EPS (Basic, Before Extraordinaries)0.980.80-0.60
EPS (Diluted)0.910.75-0.60
EBITDA10890-34
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio60.5655.00—
Price To Sales Ratio5.634.50—
Gross Margin54.6454.5785.58
Operating Margin12.3311.36-10.87
Net Margin9.688.70-10.17
Shares Outstanding777471
Market Capitalization4,2433,053—
Operating Lease Expense
———
Insider Trading Volume
$58.03$51.71$45.38$39.06$32.74● Close Price0.00M6.77M13.53M20.30M27.07MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
McCain Tracey LDirectorMay 29 '26Option Exercise0.005,598015,345Jun 02 12:00 AM
Cole G BradleyDirectorMay 29 '26Option Exercise0.005,598015,345Jun 02 12:00 AM
Quart Barry DDirectorMay 29 '26Option Exercise0.005,598015,345Jun 02 12:00 AM
Popovits Kimberly JDirectorMay 29 '26Option Exercise0.005,598015,345Jun 02 12:00 AM
Malley ThomasDirectorMay 29 '26Option Exercise0.005,598015,345Jun 02 12:00 AM
Levy Richard SDirectorMay 29 '26Option Exercise0.005,598021,956Jun 02 12:00 AM
Paolini John F.CHIEF MEDICAL OFFICERMay 01 '26Sale53.7158,4243,137,82365,623May 05 12:00 AM
Paolini John F.CHIEF MEDICAL OFFICERMay 01 '26Option Exercise10.36116,8481,210,546124,047May 05 12:00 AM
Patel Sanj KCHAIRMAN & CEOMay 01 '26Sale54.0248,5652,623,4810May 01 12:00 AM
Patel Sanj KCHAIRMAN & CEOMay 01 '26Option Exercise30.9397,1303,004,23048,565May 01 12:00 AM
Patel Sanj KCHAIRMAN & CEOApr 30 '26Option Exercise30.934,282132,44248,565Apr 30 12:00 AM
Patel Sanj KCHAIRMAN & CEOApr 30 '26Sale54.012,141115,6350Apr 30 12:00 AM
Patel Sanj KCHAIRMAN & CEOApr 29 '26Option Exercise30.9345,0881,394,57250,706Apr 30 12:00 AM
Patel Sanj KCHAIRMAN & CEOApr 28 '26Sale51.86483,65425,081,9910Apr 30 12:00 AM
Patel Sanj KCHAIRMAN & CEOApr 28 '26Option Exercise12.56967,30812,150,306483,654Apr 30 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR